Healthcare News and Research

Latest Healthcare News and Research

Type 2 diabetes: Patients reporting better quality of communication by their physician show improved self-care

New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on’), is linked to future patient self-care and well-being.1 Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.

7 Jun 2015

Janssen begins rolling submission of daratumumab BLA to FDA for treatment of patients with multiple myeloma

Janssen Research & Development, LLC has initiated the rolling submission of its Biologic License Application (BLA) for daratumumab to the U.S. Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who are double refractory to a PI and an IMiD.

7 Jun 2015

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

Results from a new study of Japanese patients with type 2 diabetes showed once-weekly Trulicity 0.75 mg provided greater hemoglobin A1c (A1C) reduction compared to once-daily Victoza 0.9 mg after 52 weeks of treatment. Eli Lilly and Company will present these data at the 75th American Diabetes Association Scientific Sessions in Boston.

7 Jun 2015

Resting-state connectivity changes underpinning ICDs identified

The presence of impulse control disorders is associated with reduced resting-state connectivity between part of the associative striatum and both associative and limbic cortical regions in patients with Parkinson’s disease, a study suggests.

5 Jun 2015

PALOMA3 supports palbociclib use in advanced breast cancer

Advanced breast cancer patients who have failed prior endocrine treatment may receive a progression-free survival benefit if palbociclib is added to fulvestrant, a phase III trial indicates.

5 Jun 2015

Shorter washout period during transition from natalizumab supported

A prematurely halted trial provides support for a relatively short washout period when transitioning patients with relapsing–remitting multiple sclerosis from natalizumab to fingolimod.

5 Jun 2015

Severe nonmotor symptom burden common in early Parkinson’s

Almost all patients with early Parkinson’s disease have nonmotor symptoms, with more than a third having a severe burden of symptoms, a study shows.

5 Jun 2015

Cardinal Health announces plans to acquire The Harvard Drug Group

Cardinal Health today announced plans to acquire The Harvard Drug Group (THDG), a distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers.

5 Jun 2015

Women contribute around $3 trillion to global health care, but almost half of this is unpaid, unrecognised

A major new Commission on women and health has found that women are contributing around $3 trillion to global health care, but nearly half of this (2.35% of global GDP) is unpaid and unrecognised.

5 Jun 2015

Boston Scientific announces European launch of Precision Novi SCS System

Boston Scientific announces the European launch of the Precision Novi Spinal Cord Stimulator (SCS) System at the International Neuromodulation Society in Montreal, Canada. The 16-contact primary cell device has CE Mark for the treatment of chronic pain, and is the smallest high-capacity primary cell device currently available.

5 Jun 2015

Griffith student finds success in medical tourism

The world of medical tourism was not one that Dan Donner had ever considered as a potential career path, but today he can be found dividing his time between study at Griffith University and running a flourishing business in Thailand.

5 Jun 2015

Our Lady of the Lake Children's Hospital opens pediatric specialty clinic in Lafayette, Louisiana

Our Lady of the Lake Children's Hospital opened its first pediatric specialty clinic outside of the Baton Rouge area on June 3. The Pediatric Specialty Clinic in Lafayette, Louisiana will offer specialized outpatient care for pediatric gastroenterology.

5 Jun 2015

Montefiore's School Health Program awarded $3 million grant to support teen pregnancy prevention initiative

Montefiore Health System announced today that its School Health Program received a $3 million grant from the Jerome L. Greene Foundation, which is dedicated to furthering the causes of education, the arts, health, and social justice. The generous pledge will support a new teen pregnancy prevention initiative in the Bronx, which has one of the highest rates of teen pregnancy in the nation.

5 Jun 2015

Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured breast implants

Actavis plc, which recently completed the acquisition of Allergan, Inc., today announced that the company has received approval from the U.S. Food and Drug Administration to market NATRELLE INSPIRA round gel-filled textured breast implants, offering women undergoing reconstruction, augmentation or revision surgery another breast shaping option for a customized result.

5 Jun 2015

Transwestern named a finalist in 2015 NJBIZ Healthcare Heroes awards program

Transwestern today announces it has been named one of five finalists in the 2015 NJBIZ Healthcare Heroes awards program. Nominated in the "Workplace Wellness Hero" category, Transwestern is being recognized for its company-wide wellness program and efforts to promote a healthy work environment.

4 Jun 2015

Sexual violence against children significantly higher in low- and middle-income countries

Sexual violence against children is a significant problem in many low- and middle-income countries. At least 25 percent of females and 10 percent of males experienced some form of childhood sexual violence in the majority of seven countries studied, according to findings from the Violence Against Children Surveys (VACS) released today in the Morbidity and Mortality Weekly Report (MMWR) by the Centers for Disease Control and Prevention.

4 Jun 2015

$Elotuzumab boosts response in relapsed, refractory multiple myeloma$